Natco Pharma, 524816, NATCOPHARM Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

16,176.74
36.73
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

16,283.54
0.70%
4.15

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

16.45
20.47
1.21

EBITDA CAGR (%)

10 Years
5 Years
3 Years

24.14
30.08
3.07

PAT CAGR (%)

10 Years
5 Years
3 Years

29.46
36.78
9.86

P:E (Median)

8 Years
5 Years
3 Years

28.25
26.16
20.74

P:BV (Average)

8 Years
5 Years
3 Years

5.26
5.63
4.16

EV:EBITDA (Average)

8 Years
5 Years
3 Years

20.55
21.82
14.93

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 532.20 464.70 14.53% 420.10 416.30 0.91% 447.70 531.90 -15.83% 457.70 522.40 -12.39%
Expenses 359.60 269.00 33.68% 301.50 266.10 13.30% 321.00 321.50 -0.16% 320.70 291.60 9.98%
EBITDA 172.60 195.70 -11.80% 118.60 150.20 -21.04% 126.70 210.40 -39.78% 137.00 230.80 -40.64%
EBIDTM 32.43% 42.11% -0.29% 36.08% 28.30% 39.56% 29.93% 44.18%
Other Income 19.90 20.40 -2.45% 38.60 30.70 25.73% 30.90 23.70 30.38% 33.90 39.70 -14.61%
Interest 3.30 6.20 -46.77% 3.50 5.20 -32.69% 5.20 7.20 -27.78% 5.70 3.70 54.05%
Depreciation 27.60 21.60 27.78% 29.80 21.30 39.91% 25.10 20.50 22.44% 21.60 20.00 8.00%
PBT 161.60 188.30 -14.18% 123.90 154.40 -19.75% 127.30 206.40 -38.32% 143.60 246.80 -41.82%
Tax 34.90 40.60 -14.04% 22.90 31.00 -26.13% 23.70 44.40 -46.62% 21.40 53.70 -60.15%
PAT 126.70 147.70 -14.22% 101.00 123.40 -18.15% 103.60 162.00 -36.05% 122.20 193.10 -36.72%
PATM 23.81% 31.78% 2.87% 29.64% 23.14% 30.46% 26.70% 36.96%
EPS 6.96 8.11 -14.18% 5.55 6.78 -18.14% 5.69 8.90 -36.07% 6.71 10.60 -36.70%

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 563.40 492.30 14.44% 454.80 455.70 -0.20% 482.20 556.70 -13.38% 485.70 543.50 -10.63%
Expenses 392.30 301.00 30.33% 326.50 307.40 6.21% 353.50 348.30 1.49% 351.40 323.00 8.79%
EBITDA 171.10 191.30 -10.56% 128.30 148.30 -13.49% 128.70 208.40 -38.24% 134.30 220.50 -39.09%
EBIDTM 30.37% 38.86% 14.01% 32.54% 26.69% 37.43% 27.65% 40.57%
Other Income 18.70 21.00 -10.95% 22.40 31.00 -27.74% 30.80 23.30 32.19% 33.20 40.00 -17.00%
Interest 3.70 6.50 -43.08% 3.50 5.20 -32.69% 5.30 6.30 -15.87% 6.20 5.00 24.00%
Depreciation 28.00 22.00 27.27% 30.50 21.70 40.55% 25.40 20.70 22.71% 21.90 20.20 8.42%
PBT 158.10 183.80 -13.98% 116.70 152.40 -23.43% 128.80 204.70 -37.08% 139.40 235.30 -40.76%
Tax 36.00 41.00 -12.20% 23.50 32.00 -26.56% 24.40 45.40 -46.26% 21.70 53.70 -59.59%
PAT 122.10 142.80 -14.50% 93.20 120.40 -22.59% 104.40 159.30 -34.46% 117.70 181.60 -35.19%
PATM 21.67% 29.01% 7.11% 26.42% 21.65% 28.62% 24.23% 33.41%
EPS 6.71 7.84 -14.41% 5.12 6.61 -22.54% 5.73 8.75 -34.51% 6.46 9.97 -35.21%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,857.70 1,790.20 1,986.30 2,091.30 1,958.00 1,021.40 715.55 622.34 557.85 435.68 348.35 Net Sales Growth -4.01% -9.87% -5.02% 6.81% 91.70% 42.74% 14.98% 11.56% 28.04% 25.07% Cost Of Goods Sold 885.42 369.80 339.10 388.50 572.80 256.30 170.70 150.73 164.96 134.28 100.98 Gross Profit 972.28 1,420.40 1,647.20 1,702.80 1,385.20 765.10 544.85 471.61 392.89 301.39 247.37 GP Margin 52.34% 79.34% 82.93% 81.42% 70.75% 74.91% 76.14% 75.78% 70.43% 69.18% 71.01% Total Expenditure 1,302.80 1,212.20 1,169.80 1,162.90 1,266.00 740.70 486.99 435.76 400.92 324.31 261.00 Power & Fuel Cost - 62.40 59.60 56.10 50.50 43.70 40.49 40.69 36.98 26.32 21.19 % Of Sales - 3.49% 3.00% 2.68% 2.58% 4.28% 5.66% 6.54% 6.63% 6.04% 6.08% Employee Cost - 356.10 340.20 312.20 232.10 171.90 116.19 94.22 85.36 67.13 53.44 % Of Sales - 19.89% 17.13% 14.93% 11.85% 16.83% 16.24% 15.14% 15.30% 15.41% 15.34% Manufacturing Exp. - 230.40 188.80 175.10 134.20 100.60 65.41 70.48 61.85 43.21 40.03 % Of Sales - 12.87% 9.51% 8.37% 6.85% 9.85% 9.14% 11.32% 11.09% 9.92% 11.49% General & Admin Exp. - 111.40 112.80 96.00 78.30 56.90 48.57 46.44 31.60 28.24 20.99 % Of Sales - 6.22% 5.68% 4.59% 4.00% 5.57% 6.79% 7.46% 5.66% 6.48% 6.03% Selling & Distn. Exp. - 22.60 80.60 98.00 128.80 88.40 34.29 24.47 13.46 18.44 12.36 % Of Sales - 1.26% 4.06% 4.69% 6.58% 8.65% 4.79% 3.93% 2.41% 4.23% 3.55% Miscellaneous Exp. - 59.50 48.70 37.00 69.30 22.90 11.33 8.73 6.72 6.68 12.36 % Of Sales - 3.32% 2.45% 1.77% 3.54% 2.24% 1.58% 1.40% 1.20% 1.53% 3.45% EBITDA 554.90 578.00 816.50 928.40 692.00 280.70 228.56 186.58 156.93 111.37 87.35 EBITDA Margin 29.87% 32.29% 41.11% 44.39% 35.34% 27.48% 31.94% 29.98% 28.13% 25.56% 25.08% Other Income 123.30 123.80 129.80 39.40 13.20 12.90 13.57 15.71 11.94 9.51 5.19 Interest 17.70 20.60 18.80 14.70 17.50 21.90 30.13 34.06 25.12 22.96 14.20 Depreciation 104.10 98.10 80.10 65.50 53.60 50.20 42.46 26.79 19.84 15.41 14.35 PBT 556.40 583.10 847.40 887.60 634.10 221.50 169.54 141.45 123.91 82.51 63.98 Tax 102.90 108.60 180.30 189.40 139.30 45.00 1.48 31.26 34.18 20.38 11.86 Tax Rate 18.49% 18.62% 21.28% 21.34% 21.97% 20.32% 0.96% 22.10% 30.43% 24.70% 18.54% PAT 453.50 474.50 667.10 698.20 494.80 176.50 152.93 110.19 78.14 62.13 52.12 PAT before Minority Interest 453.50 474.50 667.10 698.20 494.80 176.50 152.93 110.19 78.14 62.13 52.12 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 24.41% 26.51% 33.59% 33.39% 25.27% 17.28% 21.37% 17.71% 14.01% 14.26% 14.96% PAT Growth -27.58% -28.87% -4.45% 41.11% 180.34% 15.41% 38.79% 41.02% 25.77% 19.21% EPS 24.90 26.06 36.63 38.34 27.17 9.69 8.40 6.05 4.29 3.41 2.86

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales 1,986.10 2,094.50 2,184.80 2,020.20 1,141.30 825.28 738.89 660.53 523.72 459.68 456.70 Net Sales Growth -3.03% -4.13% 8.15% 77.01% 38.29% 11.69% 11.86% 26.12% 13.93% 0.65% Cost Of Goods Sold 5,033.70 354.20 411.10 599.10 341.10 242.37 233.23 242.80 203.08 186.08 210.06 Gross Profit -3,047.60 1,740.30 1,773.70 1,421.10 800.20 582.90 505.67 417.73 320.64 273.60 246.64 GP Margin -153.45% 83.09% 81.18% 70.34% 70.11% 70.63% 68.44% 63.24% 61.22% 59.52% 54.00% Total Expenditure 1,423.70 1,299.70 1,256.40 1,336.80 868.70 611.90 559.56 510.60 414.38 369.11 365.29 Power & Fuel Cost - 59.60 56.20 50.50 43.70 43.24 44.77 38.75 26.88 21.41 15.13 % Of Sales - 2.85% 2.57% 2.50% 3.83% 5.24% 6.06% 5.87% 5.13% 4.66% 3.31% Employee Cost - 355.90 325.60 243.20 189.60 136.92 112.77 102.29 80.05 66.39 57.25 % Of Sales - 16.99% 14.90% 12.04% 16.61% 16.59% 15.26% 15.49% 15.28% 14.44% 12.54% Manufacturing Exp. - 207.70 182.60 141.20 105.20 73.04 76.57 65.10 43.32 40.18 38.80 % Of Sales - 9.92% 8.36% 6.99% 9.22% 8.85% 10.36% 9.86% 8.27% 8.74% 8.50% General & Admin Exp. - 130.50 105.50 88.10 73.40 63.66 56.21 39.49 32.37 27.32 19.61 % Of Sales - 6.23% 4.83% 4.36% 6.43% 7.71% 7.61% 5.98% 6.18% 5.94% 4.29% Selling & Distn. Exp. - 137.20 136.90 143.20 91.60 37.36 26.16 14.82 19.02 13.24 12.56 % Of Sales - 6.55% 6.27% 7.09% 8.03% 4.53% 3.54% 2.24% 3.63% 2.88% 2.75% Miscellaneous Exp. - 54.60 38.50 71.50 24.10 15.31 9.85 7.36 9.66 14.50 12.56 % Of Sales - 2.61% 1.76% 3.54% 2.11% 1.86% 1.33% 1.11% 1.84% 3.15% 2.60% EBITDA 562.40 794.80 928.40 683.40 272.60 213.38 179.33 149.93 109.34 90.57 91.41 EBITDA Margin 28.32% 37.95% 42.49% 33.83% 23.89% 25.86% 24.27% 22.70% 20.88% 19.70% 20.02% Other Income 105.10 130.20 40.40 13.90 9.90 14.91 16.71 12.41 9.14 4.64 4.62 Interest 18.70 19.30 15.40 18.50 22.90 31.68 36.62 26.31 23.04 14.20 14.69 Depreciation 105.80 81.00 66.20 54.40 51.00 47.27 30.44 22.12 15.91 15.88 19.73 PBT 543.00 824.70 887.20 624.40 208.60 149.34 128.98 113.90 79.54 65.12 61.61 Tax 105.60 182.30 192.00 139.50 52.80 3.95 30.87 36.44 21.07 13.21 13.66 Tax Rate 19.45% 22.11% 21.64% 22.34% 25.31% 2.94% 23.93% 35.61% 26.49% 20.29% 22.17% PAT 437.40 644.40 696.20 486.00 157.10 134.62 102.74 71.87 59.61 53.51 48.72 PAT before Minority Interest 439.50 642.40 695.20 484.90 155.80 130.27 98.11 65.88 58.47 51.91 47.95 Minority Interest 2.10 2.00 1.00 1.10 1.30 4.35 4.63 5.99 1.14 1.60 0.77 PAT Margin 22.02% 30.77% 31.87% 24.06% 13.77% 16.31% 13.90% 10.88% 11.38% 11.64% 10.67% PAT Growth -27.59% -7.44% 43.25% 209.36% 16.70% 31.03% 42.95% 20.57% 11.40% 9.83% EPS 24.02 35.39 38.23 26.69 8.63 7.39 5.64 3.95 3.27 2.94 2.68

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 3,869.50 3,563.20 3,125.40 1,699.70 1,336.30 878.99 732.90 537.58 467.46 346.91 Share Capital 36.40 36.50 36.90 34.90 34.80 33.23 33.07 31.37 31.15 28.15 Total Reserves 3,809.50 3,495.80 3,064.30 1,649.40 1,291.80 845.76 699.83 506.21 436.32 318.76 Non-Current Liabilities 117.50 83.10 47.00 37.70 27.90 117.53 148.62 187.15 170.94 160.44 Secured Loans 0.00 0.00 0.00 0.00 0.00 96.28 94.97 137.07 133.88 125.21 Unsecured Loans 0.90 0.00 0.00 0.00 0.00 0.00 0.00 0.05 0.22 0.22 Long Term Provisions 90.20 71.00 32.40 21.90 12.50 9.19 10.63 8.21 6.59 8.67 Current Liabilities 659.70 709.80 563.80 609.70 478.50 398.31 294.71 332.75 250.77 188.78 Trade Payables 234.20 201.80 245.40 251.40 270.10 115.34 99.18 96.38 83.86 72.99 Other Current Liabilities 93.40 108.50 131.70 122.80 110.90 113.32 96.48 88.30 81.84 43.65 Short Term Borrowings 313.10 384.50 173.00 220.60 96.00 168.54 98.63 147.74 81.64 72.02 Short Term Provisions 19.00 15.00 13.70 14.90 1.50 1.11 0.41 0.33 3.42 0.12 Total Liabilities 4,646.70 4,356.10 3,736.20 2,347.10 1,842.70 1,394.83 1,176.23 1,057.48 889.17 696.13 Net Block 1,574.50 1,214.90 1,015.30 829.00 705.60 572.74 528.98 470.56 301.81 254.15 Gross Block 2,133.70 1,678.20 1,399.60 1,151.00 975.90 783.12 690.82 605.69 417.16 354.10 Accumulated Depreciation 559.20 463.30 384.30 322.00 270.30 210.39 161.84 135.13 115.35 99.95 Non Current Assets 2,406.80 2,088.70 1,682.00 1,312.00 1,051.80 950.65 838.88 748.95 616.59 462.59 Capital Work in Progress 517.80 637.50 480.00 336.20 211.90 100.77 92.94 78.37 164.43 75.98 Non Current Investment 186.10 117.60 101.30 85.90 71.70 131.15 88.58 76.76 74.16 69.05 Long Term Loans & Adv. 124.30 116.40 83.10 60.40 62.00 142.47 125.16 120.66 75.78 62.46 Other Non Current Assets 4.10 2.30 2.30 0.50 0.60 3.52 3.22 2.61 0.42 0.96 Current Assets 2,239.90 2,267.40 2,054.20 1,035.10 790.90 444.18 337.35 308.52 272.58 233.54 Current Investments 5.00 126.80 48.30 8.90 22.10 0.12 0.32 0.81 0.74 2.14 Inventories 524.40 508.40 425.80 336.90 351.90 198.35 161.97 128.32 97.28 93.02 Sundry Debtors 536.70 491.60 606.00 468.90 255.80 188.96 115.85 126.46 93.34 70.37 Cash & Bank 54.10 262.70 172.10 25.10 40.20 7.19 7.70 7.50 33.70 30.97 Other Current Assets 1,119.70 100.60 53.20 25.70 120.90 49.57 51.53 45.42 47.52 37.03 Short Term Loans & Adv. 1,025.90 777.30 748.80 169.60 95.50 43.99 47.35 41.32 40.89 35.87 Net Current Assets 1,580.20 1,557.60 1,490.40 425.40 312.40 45.87 42.64 -24.23 21.81 44.76 Total Assets 4,646.70 4,356.10 3,736.20 2,347.10 1,842.70 1,394.83 1,176.23 1,057.47 889.17 696.13

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 3,489.00 3,072.20 1,649.30 1,295.70 846.05 725.88 533.54 473.63 352.43 305.74 Share Capital 36.50 36.90 34.90 34.80 33.23 33.07 31.37 31.15 28.15 28.15 Total Reserves 3,421.70 3,011.40 1,599.00 1,251.20 812.82 692.80 502.17 442.49 324.29 277.59 Non-Current Liabilities 83.40 47.10 37.70 28.00 119.23 150.67 191.46 171.34 160.44 146.34 Secured Loans 0.00 0.00 0.00 0.00 94.03 92.20 135.62 133.88 125.21 114.02 Unsecured Loans 0.00 0.00 0.00 0.00 2.99 3.28 2.21 0.22 0.22 5.49 Long Term Provisions 71.00 32.40 21.90 12.50 9.50 11.09 8.62 6.59 8.67 0.00 Current Liabilities 728.70 592.00 626.50 493.10 413.74 312.28 344.87 259.35 193.38 97.29 Trade Payables 217.00 269.10 262.70 275.60 125.30 109.79 105.85 92.36 76.60 82.72 Other Current Liabilities 109.80 133.40 127.10 114.20 118.56 102.18 90.21 81.91 43.86 8.79 Short Term Borrowings 386.30 173.20 221.60 98.40 168.54 98.63 147.74 81.64 72.02 0.00 Short Term Provisions 15.60 16.30 15.10 4.90 1.33 1.69 1.07 3.44 0.91 5.78 Total Liabilities 4,303.10 3,715.10 2,317.60 1,821.70 1,384.05 1,195.71 1,080.41 905.20 707.31 554.31 Net Block 1,227.20 1,018.60 833.00 710.10 709.97 644.74 582.75 319.56 270.16 261.80 Gross Block 1,696.10 1,407.60 1,158.70 983.30 939.98 819.89 726.97 440.33 374.37 356.86 Accumulated Depreciation 468.90 389.00 325.70 273.20 225.82 171.11 140.57 117.34 104.21 95.06 Non Current Assets 1,955.90 1,584.40 1,230.30 984.70 901.08 827.57 749.94 612.42 460.37 361.69 Capital Work in Progress 637.60 480.00 336.30 211.80 128.96 123.78 105.84 164.43 75.98 39.60 Non Current Investment 19.90 8.10 0.10 0.10 1.57 1.57 1.54 61.79 61.79 60.29 Long Term Loans & Adv. 68.90 75.40 60.40 62.10 57.03 54.25 57.20 66.22 51.49 0.00 Other Non Current Assets 2.30 2.30 0.50 0.60 3.54 3.24 2.61 0.42 0.96 0.00 Current Assets 2,347.20 2,130.70 1,087.30 837.00 482.97 368.14 330.48 292.79 246.95 192.62 Current Investments 148.70 68.40 32.10 22.10 0.12 0.32 0.81 0.74 0.82 0.31 Inventories 529.00 438.40 348.90 357.30 220.00 181.12 146.02 110.39 102.23 77.44 Sundry Debtors 506.20 637.50 475.20 261.60 192.43 118.80 129.71 94.69 70.98 57.24 Cash & Bank 279.50 183.70 35.80 45.20 13.36 11.05 10.78 36.63 32.37 8.12 Other Current Assets 883.80 53.20 25.80 25.40 57.06 56.85 43.14 50.34 40.55 49.52 Short Term Loans & Adv. 784.20 749.50 169.50 125.40 40.97 52.46 38.85 41.84 36.73 49.05 Net Current Assets 1,618.50 1,538.70 460.80 343.90 69.23 55.85 -14.39 33.44 53.56 95.32 Total Assets 4,303.10 3,715.10 2,317.60 1,821.70 1,384.05 1,195.71 1,080.42 905.21 707.32 554.31

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 422.50 698.80 476.40 329.80 189.90 124.55 171.79 70.02 68.01 32.29 PBT 583.10 847.40 887.60 634.10 221.50 154.41 141.45 112.33 82.51 63.98 Adjustment 45.20 12.10 74.40 99.80 81.70 62.73 56.69 45.53 35.77 34.34 Changes in Working Capital -100.70 14.20 -281.20 -281.70 -68.50 -72.49 6.11 -65.58 -27.73 -48.27 Cash after chg. in Working capital 527.60 873.70 680.80 452.20 234.70 144.64 204.25 92.27 90.56 50.06 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -105.10 -174.90 -204.40 -122.40 -44.80 -20.09 -32.46 -22.24 -22.54 -17.77 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -165.00 -645.20 -1,131.10 -290.60 -249.30 -147.95 -130.64 -124.24 -128.57 -83.41 Net Fixed Assets -335.80 -436.10 -392.40 -299.40 -303.91 -100.13 -99.70 -102.47 -151.51 -71.49 Net Investments 53.30 -94.80 -54.80 -1.00 37.47 -42.37 -11.33 -2.67 -3.71 8.04 Others 117.50 -114.30 -683.90 9.80 17.14 -5.45 -19.61 -19.10 26.65 -19.96 Cash from Financing Activity -261.10 -52.20 652.00 -45.60 151.40 22.80 -40.96 29.17 61.97 79.50 Net Cash Inflow / Outflow -3.60 1.40 -2.70 -6.40 92.00 -0.59 0.19 -25.04 1.41 28.38 Opening Cash & Equivalents 11.50 10.10 12.80 19.20 -170.00 6.86 6.67 31.71 30.30 1.91 Closing Cash & Equivalent 7.90 11.50 10.10 12.80 -76.80 6.27 6.86 6.67 31.71 30.30

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 668.80 463.60 345.80 112.20 92.67 144.03 61.19 64.94 36.99 77.37 PBT 824.70 887.20 624.40 208.60 134.22 128.98 102.32 79.54 65.12 61.61 Adjustment 14.10 75.60 100.20 90.50 68.14 65.72 48.87 36.97 38.87 44.21 Changes in Working Capital 8.80 -294.60 -253.00 -140.70 -85.96 -16.11 -67.39 -27.97 -48.50 -11.24 Cash after chg. in Working capital 847.60 668.20 471.60 158.40 116.41 178.58 83.80 88.54 55.49 94.58 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -178.80 -204.60 -125.80 -46.20 -23.74 -34.55 -22.61 -23.60 -18.50 -17.21 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -612.20 -1,115.50 -299.40 -175.50 -114.75 -108.92 -107.07 -126.94 -88.78 -60.85 Net Fixed Assets -436.10 -392.40 -299.40 -303.91 -100.13 -99.70 -102.47 -151.51 -71.49 -38.56 Net Investments -94.80 -54.80 -1.00 37.47 -42.37 -11.33 -2.67 -3.71 8.04 -20.13 Others -81.30 -668.30 1.00 90.94 27.75 2.11 -1.93 28.28 -25.33 -2.16 Cash from Financing Activity -50.90 650.90 -47.70 154.00 29.07 -35.27 26.31 62.78 77.10 -34.14 Net Cash Inflow / Outflow 5.70 -1.00 -1.30 90.70 6.99 -0.15 -19.57 0.78 25.31 -17.63 Opening Cash & Equivalents 21.70 23.50 24.20 -164.10 10.22 9.95 34.64 31.70 6.53 27.39 Closing Cash & Equivalent 28.30 21.70 23.50 -74.20 12.44 10.22 9.95 34.64 31.70 6.95

Financial Ratios

Consolidated /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 211.31 193.55 168.09 96.52 76.24 52.90 221.60 171.35 150.08 123.24 ROA 10.54% 16.49% 22.95% 23.62% 10.90% 11.90% 9.87% 8.03% 7.84% 8.48% ROE 12.86% 20.11% 29.18% 32.87% 16.00% 18.97% 17.35% 15.55% 15.26% 16.08% ROCE 14.85% 23.91% 34.58% 38.71% 18.48% 17.10% 19.04% 17.19% 16.32% 15.83% Fixed Asset Turnover 0.99 1.29 1.65 1.88 1.20 0.99 0.97 1.10 1.15 1.05 Receivable days 99.38 100.85 93.04 66.04 76.63 76.52 70.40 70.98 67.50 64.49 Inventory Days 99.81 85.83 66.02 62.77 94.81 90.45 84.34 72.86 78.47 81.84 Payable days 66.65 73.69 81.82 79.78 95.04 82.23 86.11 84.32 94.20 106.01 Cash Conversion Cycle 132.54 112.99 77.23 49.02 76.39 84.74 68.63 59.52 51.78 40.32 Total Debt/Equity 0.08 0.11 0.06 0.13 0.08 0.35 0.32 0.62 0.55 0.63 Interest Cover 29.31 46.07 61.38 37.23 11.11 6.12 5.15 5.47 4.59 5.51

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 189.49 165.22 93.63 73.91 50.91 219.48 170.06 152.06 125.21 108.62 ROA 16.02% 23.05% 23.43% 9.72% 10.10% 8.62% 6.64% 7.25% 8.23% 8.88% ROE 19.75% 29.70% 33.21% 14.62% 16.57% 15.58% 13.08% 14.16% 15.77% 17.02% ROCE 23.71% 35.28% 39.21% 18.04% 15.62% 18.02% 16.04% 15.72% 15.90% 18.83% Fixed Asset Turnover 1.35 1.72 1.93 1.23 0.95 0.96 1.14 1.30 1.27 1.38 Receivable days 99.65 92.22 65.12 70.27 67.76 60.90 61.30 56.98 50.31 47.13 Inventory Days 84.29 65.25 62.41 89.35 87.33 80.17 70.04 73.13 70.50 62.46 Payable days 72.53 81.42 78.30 85.42 73.36 74.09 73.36 79.03 83.93 87.92 Cash Conversion Cycle 111.42 76.05 49.23 74.21 81.73 66.99 57.98 51.07 36.89 21.67 Total Debt/Equity 0.11 0.06 0.14 0.09 0.37 0.33 0.63 0.55 0.62 0.39 Interest Cover 43.73 58.61 34.75 10.11 5.24 4.52 4.89 4.45 5.59 5.19

Top Investors:

east bridge capital master fund i ltd

icici prudential pharma healthcare and diaganostics

plenty private equity fii i limited

nomura singapore limited

mirae asset emerging bluechip fund

sbi contra fund

teacher retirement system of texas - self managed 4

iepf

qualified institutional buyers

Annual Reports:

News Update:

Natco Pharma - Quarterly Results
12th Aug 2020, 14:26 PM

Read More
Natco Pharma’s arm enters into settlement agreement with Celgene
10th Jul 2020, 11:22 AM

The company’s arm entered into settlement agreement for the product Lenalidomide Capsules in Canada
Read More

Natco Pharma Ltd.

Pharmaceuticals & Drugs - Global

BSE: 524816 | NSE: NATCOPHARM

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Natco Pharma Ltd.

Pharmaceuticals & Drugs - Global

BSE: 524816 | NSE: NATCOPHARM

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: